Q1 FY27 results: Revenue up 14% YoY; insurance gain lifts PAT; subsidiary sold to promoter group

Exceptional ItemRelated Party TransactionsResults View source PDF Explain this filing

SHK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+16.4%Reaction day

₹143.01

prior close

₹154.49

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+16.0% vs market

Specialty Chemicals peers, median of 93sector+0.5%+16.0% vs sector

On the reaction day the stock moved 16.0 pts more than Nifty Microcap 250 and 16.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.0

10m

+5.6

15m

+7.2

30m

+6.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+16.4+0.5+16.0+0.5+16.0

Next day

+19.3-0.1+19.4-0.9+20.2

+14.7+1.0+13.7-0.2+14.9

+15.6+2.3+13.3+0.7+14.9

+16.2+2.8+13.4+1.2+15.0

+17.5+4.1+13.4+1.6+15.8

+16.7+4.5+12.2+2.2+14.5

15d

+11.5+4.8+6.7+1.0+10.5

+5.3+6.4-1.2+3.2+2.1

-2.6+5.5-8.2+1.8-4.5

-8.4-1.7-6.7-3.5-4.9

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

S H Kelkar Q1 FY27: Consolidated revenue Rs 662.42 cr, up 14.1% YoY from Rs 580.50 cr. Flavours segment jumped 63% YoY. PAT from continuing ops Rs 44.85 cr vs Rs 25.61 cr, aided by Rs 29.95 cr exceptional gain from insurance claim related to April 2024 Vashivali plant fire. Total PAT Rs 45.43 cr; EPS Rs 3.28 vs Rs 1.85. Board approved sale of wholly owned subsidiary Keva Ventures to promoter group firm Keva Aromatics for Rs 45.85 lakh. Unmodified auditor review.

Likely market impact

Insurance-driven PAT may not repeat. Subsidiary sale is a related-party deal to promoter group, but small. Flavours segment growth is a positive signal.